ATEC Stock Overview
A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Alphatec Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.55 |
| 52 Week High | US$17.34 |
| 52 Week Low | US$5.74 |
| Beta | 1.4 |
| 11 Month Change | -36.35% |
| 3 Month Change | -51.77% |
| 1 Year Change | -59.42% |
| 33 Year Change | -55.14% |
| 5 Year Change | 5.31% |
| Change since IPO | -93.92% |
Recent News & Updates
Recent updates
Alphatec: Creating Some Real Back Pain For Its Shareholders
Aug 05Potential Upside For Alphatec Holdings, Inc. (NASDAQ:ATEC) Not Without Risk
Jul 15
Shareholders May Not Be So Generous With Alphatec Holdings, Inc.'s (NASDAQ:ATEC) CEO Compensation And Here's Why
Jun 06Alphatec: Continued Losses Cause Continued Dilution
May 10Would Alphatec Holdings (NASDAQ:ATEC) Be Better Off With Less Debt?
Apr 22Alphatec Holdings, Inc. (NASDAQ:ATEC) Screens Well But There Might Be A Catch
Mar 31Alphatec Holdings: Taking Market Share Amid Strong Execution - Buy
Feb 12Market Participants Recognise Alphatec Holdings, Inc.'s (NASDAQ:ATEC) Revenues
Dec 18Why We're Not Concerned About Alphatec Holdings, Inc.'s (NASDAQ:ATEC) Share Price
Apr 19Alphatec Holdings (NASDAQ:ATEC) Is Making Moderate Use Of Debt
Feb 10Is There Now An Opportunity In Alphatec Holdings, Inc. (NASDAQ:ATEC)?
Dec 23Alphatec Holdings (NASDAQ:ATEC) Is Carrying A Fair Bit Of Debt
Oct 23Alphatec: Not Having My Back (Yet)
Oct 15Alphatec GAAP EPS of -$0.36 misses by $0.05, revenue of $84M beats by $5.91M
Aug 04Alphatec Holdings (NASDAQ:ATEC) Is Carrying A Fair Bit Of Debt
Jul 22Alphatec: Profitability, FCF, Valuation A Concern Amid Macro-Climate
Jul 20Shareholder Returns
| ATEC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -34.5% | -1.3% | -5.6% |
| 1Y | -59.4% | -0.7% | 12.4% |
Return vs Industry: ATEC underperformed the US Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: ATEC underperformed the US Market which returned 15.9% over the past year.
Price Volatility
| ATEC volatility | |
|---|---|
| ATEC Average Weekly Movement | 13.0% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ATEC's share price has been volatile over the past 3 months.
Volatility Over Time: ATEC's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 839 | Pat Miles | www.atecspine.com |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
Alphatec Holdings, Inc. Fundamentals Summary
| ATEC fundamental statistics | |
|---|---|
| Market cap | US$884.90m |
| Earnings (TTM) | -US$180.91m |
| Revenue (TTM) | US$540.28m |
1.7x
P/S Ratio-5.1x
P/E RatioIs ATEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ATEC income statement (TTM) | |
|---|---|
| Revenue | US$540.28m |
| Cost of Revenue | US$165.10m |
| Gross Profit | US$375.18m |
| Other Expenses | US$556.09m |
| Earnings | -US$180.91m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.29 |
| Gross Margin | 69.44% |
| Net Profit Margin | -33.48% |
| Debt/Equity Ratio | 1,275.2% |
How did ATEC perform over the long term?
See historical performance and comparison